Giovanni Martinelli
Institute of Hematology and Medical Oncology Seragnoli
University of Bologna
Bologna
Italy
Name/email consistency: high
- Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management. Martinelli, G., Iacobucci, I., Soverini, S., Cilloni, D., Saglio, G., Pane, F., Baccarani, M. Hematol. Oncol (2006)
- Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients. Martinelli, G., Iacobucci, I., Rosti, G., Pane, F., Amabile, M., Castagnetti, F., Cilloni, D., Soverini, S., Testoni, N., Specchia, G., Merante, S., Zaccaria, A., Frassoni, F., Saglio, G., Baccarani, M. Ann. Oncol. (2006)
- New tyrosine kinase inhibitors in chronic myeloid leukemia. Martinelli, G., Soverini, S., Rosti, G., Cilloni, D., Baccarani, M. Haematologica (2005)
- Dual tyrosine kinase inhibitors in chronic myeloid leukemia. Martinelli, G., Soverini, S., Rosti, G., Baccarani, M. Leukemia (2005)
- Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Martinelli, G., Ottaviani, E., Buonamici, S., Isidori, A., Borsaru, G., Visani, G., Piccaluga, P.P., Malagola, M., Testoni, N., Rondoni, M., Nucifora, G., Tura, S., Baccarani, M. Haematologica (2003)
- Bone marrow of a patient with acute non-lymphoblastic leukaemia associated with the t(1;7)(p11;p11) chromosomal translocation. Martinelli, G., Setola, E., Ricci, P. Haematologica (2002)
- Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one. Martinelli, G., Amabile, M., Giannini, B., Terragna, C., Ottaviani, E., Soverini, S., Saglio, G., Rosti, G., Baccarani, M. Haematologica (2002)
- Molecular therapy for multiple myeloma. Martinelli, G., Tosi, P., Ottaviani, E., Soverini, S., Tura, S. Haematologica (2001)
- Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints. Martinelli, G., Terragna, C., Amabile, M., Montefusco, V., Testoni, N., Ottaviani, E., de Vivo, A., Mianulli, A., Saglio, G., Tura, S. Haematologica (2000)
- Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma. Martinelli, G., Terragna, C., Zamagni, E., Ronconi, S., Tosi, P., Lemoli, R.M., Bandini, G., Motta, M.R., Testoni, N., Amabile, M., Ottaviani, E., Vianelli, N., de Vivo, A., Gozzetti, A., Tura, S., Cavo, M. J. Clin. Oncol. (2000)
- Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response. Martinelli, G., Montefusco, V., Amabile, M., Lemoli, R.M., Terragna, C., Testoni, N., Ottaviani, E., Rosti, G., de Vivo, A., Rizzi, S., Russo, D., Bregoli, M., Tura, S. Leuk. Lymphoma (2000)
- Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation. Martinelli, G., Terragna, C., Zamagni, E., Ronconi, S., Tosi, P., Lemoli, R., Bandini, G., Testoni, N., Amabile, M., Ottaviani, E., Buonamici, S., Soverini, S., Montefusco, V., de Vivo, A., Bonifazi, F., Tura, S., Cavo, M. Haematologica (2000)
- Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells. Martinelli, G., Terragna, C., Lemoli, R.M., Cavo, M., Benni, M., Motta, M.R., Amabile, M., Ottaviani, E., Testoni, N., de Vivo, A., Tura, S. Haematologica (1999)
